Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 208

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 3
Chunk 208
---
Other, net(63)(225)(150)Changes in operating assets and liabilities, net of acquisitions:Accounts receivable207 66 (1,455)Inventories(319)(417)(686)Prepaid expenses and other assets361 (188)(264)Accounts payable and other liabilities177 3,840 1,769 Income tax assets and liabilities, net(3,208)(488)542 Cash flows from operating activities18,806 22,839 24,943 Cash flows from investing activitiesAcquisition of businesses, net of cash acquired(17,493)— (255)Other acquisitions and investments(3,024)(1,223)(539)Acquisitions of property and equipment(974)(777)(695)Purchases of investment securities(73)(77)(1,438)Sales and maturities of investment securities555 55 1,530 Other, net189 13 774 Cash flows from investing activities(20,820)(2,009)(623)Cash flows from financing activitiesProceeds from issuance of other short-term borrowings5,008 — — Repayments of other short-term borrowings(5,008)— — Proceeds from issuance of long-term debt16,963 — 2,000 Repayments of long-term debt and finance lease obligations(9,613)(4,149)(14,433)Debt issuance costs(99)(38)— Dividends paid(11,025)(10,539)(10,043)Purchases of treasury stock(1,708)(1,972)(1,487)Proceeds from the exercise of stock options214 180 262 Payments of contingent consideration liabilities— (752)(1,132)Other, net57 48 30 Cash flows from financing activities(5,211)(17,222)(24,803)Effect of exchange rate changes on cash and equivalents(65)5 (62)Net change in cash and equivalents(7,290)3,613 (545)Cash and equivalents, beginning of year12,814 9,201 9,746 Cash and equivalents, end of year$5,524 $12,814 $9,201 Other supplemental informationInterest paid, net of portion capitalized$2,811 $2,469 $2,546 Income taxes paid4,064 4,702 2,988 

 The accompanying notes are an